Abstract
Thiazolyl peptides are a class of rigid macrocyclic compounds richly populated with thiazole rings. They are highly potent antibiotics but none have been advanced to clinic due to poor aqueous solubility. Recent progress in this field prompted a reinvestigation leading to the isolation of a new thiazolyl peptide, thiazomycin, a congener of nocathiacins. Thiazomycin possesses an oxazolidine ring as part of the amino-sugar moiety in contrast to the dimethyl amino group present in nocathiacin I. The presence of the oxazolidine ring provides additional opportunities for chemical modifications that are not possible with other nocathiacins. Thiazomycin is extremely potent against Gram-positive bacteria both in vitro and in vivo. The titer of thiazomycin in the fermentation broth was very low compared to the nocathiacins I and III. The lower titer together with its sandwiched order of elution presented significant challenges in large scale purification of thiazomycin. This problem was resolved by the development of an innovative preferential protonation based one- and/or two-step chromatographic method, which was used for pilot plant scale purifications of thiazomycin. The isolation and structure elucidation of thiazomycin is herein described.
Similar content being viewed by others
Article PDF
References
Walsh CT . Antibiotics: Actions, Origin, Resistance. ASM Press, Washington DC, ( 2003)
Singh SB, Barrett JF . Empirical antibacterial drug discovery—foundation in natural products. Biochem Pharmacol 71: 1006–1015 ( 2006)
Singh SB, Jayasuriya H, Ondeyka JG, Herath KB, Zhang C, Zink DL, Tsou NN, Ball RG, Basilio A, Genilloud O, Diez MT, Vicente F, Pelaez F, Young K, Wang J . Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J Am Chem Soc 128: 11916–11920 and 15547 ( 2006)
Wang J, Soisson SM, Young K, Shoop W, Kodali S, Galgoci A, Painter R, Parthasarathy G, Tang YS, Cummings R, Ha S, Dorso K, Motyl M, Jayasuriya H, Ondeyka J, Herath K, Zhang C, Hernandez L, Allocco J, Basilio A, Tormo JR, Genilloud O, Vicente F, Pelaez F, Colwell L, Lee SH, Michael B, Felcetto T, Gill C, Silver LL, Hermes JD, Bartizal K, Barrett J, Schmatz D, Becker JW, Cully D, Singh SB . Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441: 358–361 ( 2006)
Wang J, Kodali S, Lee SH, Galgoci A, Painter R, Dorso K, Racine F, Motyl M, Hernandez L, Tinney E, Colletti S, Herath K, Cummings R, Salazar O, Gonzalez I, Basilio A, Vicente F, Genilloud O, Pelaez F, Jayasuriya H, Young K, Cully D, Singh SB . Platencin is a dual fabf and fabh inhibitor with potent in vivo antibiotic properties. Proc Natl Acad Sci USA 104: 7612–7616 ( 2007)
Jayasuriya H, Herath KB, Zhang C, Zink DL, Basilio A, Genilloud O, Diez MT, Vicente F, Gonzalez I, Salazar O, Pelaez F, Cummings R, Ha S, Wang J, Singh SB . Isolation and structure of platencin: A novel FabH and FabF dual inhibitor with potent broad spectrum antibiotic activity produced by Streptomyces platensis MA7339. Angew Chem Int Ed Engl 46: 4684–4688 ( 2007)
Bagley MC, Dale JW, Merritt EA, Xiong X . Thiopeptide antibiotics. Chem Rev 105: 685–714 ( 2005)
Hensens OD, Albers-Schonberg G . 13C NMR study of thiostrepton and thiopeptin components. J Antibiot 36: 832–845 ( 1983)
Hensens OD, Albers-Schonberg G, Anderson BF . The solution conformation of the peptide antibiotic thiostrepton: a 1H NMR study. J Antibiot 36: 799–813 ( 1983)
Northcote PT, Siegel M, Borders DB, Lee MD . Glycothiohexide alpha, a novel antibiotic produced by “Sebekia” sp., LL-14E605. III. Structural elucidation. J Antibiot 47: 901–908 ( 1994)
Northcote PT, Williams D, Manning JK, Borders DB, Maiese WM, Lee MD . Glycothiohexide alpha, a novel antibiotic produced by “Sebekia” sp., LL-14E605. II. Isolation and physical-chemical characterization. J Antibiot 47: 894–900 ( 1994)
Sasaki T, Otani T, Matsumoto H, Unemi N, Hamada M, Takeuchi T, Hori M . MJ347-81F4 A and B, novel antibiotics from Amycolatopsis sp.: Taxonomic characteristics, fermentation, and antimicrobial activity. J Antibiot 51: 715–721 ( 1998)
Li W, Leet JE, Ax HA, Gustavson DR, Brown DM, Turner L, Brown K, Clark J, Yang H, Fung-Tomc J, Lam KS . Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J Antibiot 56: 226–231 ( 2003)
Constantine KL, Mueller L, Huang S, Abid S, Lam KS, Li W, Leet JE . Conformation and absolute configuration of nocathiacin I determined by NMR spectroscopy and chiral capillary electrophoresis. J Am Chem Soc 124: 7284–7285 ( 2002)
Connolly TP, Regueiro-Ren A, Leet JE, Springer DM, Goodrich J, Huang XS, Pucci MJ, Clark JM, Bronson JJ, Ueda Y . Chemical conversion of nocathiacin I to nocathiacin II and a lactone analogue of glycothiohexide alpha. J Nat Prod 68: 550–553 ( 2005)
Hrnciar P, Ueda Y, Huang S, Leet JE, Bronson JJ . Synthesis of novel nocathiacin-class antibiotics. Condensation of glycolaldehyde with primary amides and tandem reductive amination of amadori-rearranged 2-oxoethyl intermediates. J Org Chem 67: 8789–8793 ( 2002)
Naidu BN, Sorenson ME, Zhang Y, Kim OK, Matiskella JD, Wichtowski JA, Connolly TP, Li W, Lam KS, Bronson JJ, Pucci MJ, Clark JM, Ueda Y . Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Bioorg Med Chem Lett 14: 5573–5577 ( 2004)
Naidu BN, Sorenson ME, Hudyma T, Zheng X, Zhang Y, Bronson JJ, Pucci MJ, Clark JM, Ueda Y . Synthesis and antibacterial activity of O-substituted nocathiacin I derivatives. Bioorg Med Chem Lett 14: 3743–3746 ( 2004)
Naidu BN, Sorenson ME, Bronson JJ, Pucci MJ, Clark JM, Ueda Y . Synthesis, in vitro, and in vivo antibacterial activity of nocathiacin I thiol-Michael adducts. Bioorg Med Chem Lett 15: 2069–2072 ( 2005)
Naidu BN, Sorenson ME, Matiskella JD, Li W, Sausker JB, Zhang Y, Connolly TP, Lam KS, Bronson JJ, Pucci MJ, Yang H, Ueda Y . Synthesis and antibacterial activity of nocathiacin I analogues. Bioorg Med Chem Lett 16: 3545–3549 ( 2006)
Pucci MJ, Bronson JJ, Barrett JF, DenBleyker KL, Discotto LF, Fung-Tomc JC, Ueda Y . Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics. Antimicrob Agents Chemother 48: 3697–3701 ( 2004)
Regueiro-Ren A, Ueda Y . Mild method for cleavage of dehydroalanine units: highly efficient conversion of nocathiacin I to nocathiacin IV. J Org Chem 67: 8699–8702 ( 2002)
Regueiro-Ren A, Naidu BN, Zheng X, Hudyma TW, Connolly TP, Matiskella JD, Zhang Y, Kim OK, Sorenson ME, Pucci M, Clark J, Bronson JJ, Ueda Y . Novel semi-synthetic nocathiacin antibiotics: synthesis and antibacterial activity of bis- and mono-O-alkylated derivatives. Bioorg Med Chem Lett 14: 171–175 ( 2004)
Singh SB, Occi J, Jayasuriya H, Herath K, Motyl M, Dorso K, Gill C, Hickey E, Overbye K, Barrett JF, Masurekar P . Antibacterial evaluations of thiazomycin—A potent thiazolyl peptide antibiotic from a Amycolatopsis fastidiosa. J Antibiot 60: 565–571 ( 2007)
Salazar O, Valverde A, Genilloud O . Real-time PCR for the detection and quantification of geodermatophilaceae from stone samples and identification of new members of the genus Blastococcus. Appl Environ Microbiol 72: 346–352 ( 2006)
Thompson JD, Higgins DG, Gibson TJ . CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680 ( 1994)
Felsenstein J . Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17: 368–376 ( 1981)
Junker B, Seeley A, Lester M, Kovatch M, Schmitt J, Borysewicz S, Lynch J, Zhang J, Greasham R . Use of frozen bagged seed inoculum for secondary metabolite and bioconversion processes at the pilot scale. Biotechnol Bioeng 79: 628–640 ( 2002)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jayasuriya, H., Herath, K., Ondeyka, J. et al. Isolation and Structure Elucidation of Thiazomycin. J Antibiot 60, 554–564 (2007). https://doi.org/10.1038/ja.2007.70
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ja.2007.70
Keywords
This article is cited by
-
Natural thiopeptides as a privileged scaffold for drug discovery and therapeutic development
Medicinal Chemistry Research (2019)
-
Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis
The Journal of Antibiotics (2017)
-
α,β-Dehydroamino acids in naturally occurring peptides
Amino Acids (2015)
-
Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening
The Journal of Antibiotics (2013)
-
Current approaches to exploit actinomycetes as a source of novel natural products
Journal of Industrial Microbiology & Biotechnology (2011)
